jason rippe, J.D.

Manager
Shield T3

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1321 - Increased Prevalence of Group A Streptococcus (GAS) High Level Macrolide Resistance During the COVID-19 Pandemic
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1332 - Population structure and genomic analysis of pediatric Streptococcus pyogenes clinical isolates in the United States, 2020 – 2022
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET